Abstract

BackgroundSome patients with locally advanced/metastatic non-small cell lung cancer (NSCLC) respond poorly to anti-programmed cell death protein 1 (PD-1)/anti-programmed death-ligand 1 (PD-L1) treatments. Combination with other agents may improve the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC
Fen Wang ... Qing Zhou
Journal of Thoracic Oncology | VOL. 17
Fen Wang, et. al.Fen Wang ... Qing Zhou
17 Mar 2022
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Adagrasib: A landmark in the KRASG12C-mutated NSCLC.
He Tian ... Zhenlin Yang
MedComm | VOL. 3
He Tian, et. al.He Tian ... Zhenlin Yang
25 Nov 2022
Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
Xiuning Le ... Paul K Paik
Journal of Clinical Oncology | VOL. 39
Xiuning Le, et. al.Xiuning Le ... Paul K Paik
20 May 2021
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer
Tessa S Groen-Van Schooten ... Sarah Derks
Journal for ImmunoTherapy of Cancer | VOL. 12
Tessa S Groen-Van Schooten, et. al.Tessa S Groen-Van Schooten ... Sarah Derks
01 Jul 2024
Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis
Xiaohe Zhou ... Li-Xin Wang
Journal for ImmunoTherapy of Cancer | VOL. 12
Xiaohe Zhou, et. al.Xiaohe Zhou ... Li-Xin Wang
26 Jun 2024
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study
Yu-Qi Wang ... Xin-Gang Cui
Journal for ImmunoTherapy of Cancer | VOL. 12
Yu-Qi Wang, et. al.Yu-Qi Wang ... Xin-Gang Cui
21 Jun 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani ... Francesco Pantano
Journal for ImmunoTherapy of Cancer | VOL. 12
Michele Iuliani, et. al.Michele Iuliani ... Francesco Pantano
21 Jun 2024
View more papers